IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Biomolecules and Therapeutics

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

4.04

h-Index

2022-2023

 49

Rank

2022-2023

 5127

SJR

2022-2023

 0.882

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Biomolecules and Therapeutics
Abbreviation Biomol. Ther.
Publication Type Journal
Subject Area, Categories, Scope Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)
h-index 49
Overall Rank/Ranking 5127
SCImago Journal Rank (SJR) 0.882
Impact Score 4.04
Publisher Korean Society of Applied Pharmacology
Country South Korea
ISSN 19769148, 20054483
Best Quartile Q1
Coverage History 2008-2022




About Biomolecules and Therapeutics


Biomolecules and Therapeutics is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2). It is published by Korean Society of Applied Pharmacology. The overall rank of Biomolecules and Therapeutics is 5127. According to SCImago Journal Rank (SJR), this journal is ranked 0.882. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 49. The best quartile for this journal is Q1.

The ISSN of Biomolecules and Therapeutics journal is 19769148, 20054483. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Biomolecules and Therapeutics is cited by a total of 884 articles during the last 3 years (Preceding 2022).


Biomolecules and Therapeutics Impact IF 2022-2023


The Impact IF 2022 of Biomolecules and Therapeutics is 4.04, which is computed in 2023 as per its definition. Biomolecules and Therapeutics IF is decreased by a factor of 0.31 and approximate percentage change is -7.13% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Biomolecules and Therapeutics Impact IF 2023 Prediction


Impact IF 2022 of Biomolecules and Therapeutics is 4.04. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Biomolecules and Therapeutics. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 4.04
2021 4.35
2020 4.45
2019 3.44
2018 3.14
2017 2.75
2016 2.99
2015 2.76
2014 1.93

Biomolecules and Therapeutics h-index


  Table Setting

Biomolecules and Therapeutics has an h-index of 49. It means 49 articles of this journal have more than 49 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Biomolecules and Therapeutics ISSN


The ISSN of Biomolecules and Therapeutics is 19769148, 20054483. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Biomolecules and Therapeutics Rank and SCImago Journal Rank (SJR)


The overall rank of Biomolecules and Therapeutics is 5127. According to SCImago Journal Rank (SJR), this journal is ranked 0.882. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Biomolecules and Therapeutics by Year


Year SJR
2023/2024 Coming Soon
2022 0.882
2021 0.965
2020 0.977
2019 0.920
2018 0.939
2017 0.946
2016 0.993
2015 0.868
2014 0.441

Ranking of Biomolecules and Therapeutics by Year


Year Ranking
2023/2024 Coming Soon
2022 5127
2021 4316
2020 4520
2019 4885
2018 4741
2017 4704
2016 4468
2015 5316
2014 9906

Biomolecules and Therapeutics Publisher


Table Setting

Biomolecules and Therapeutics is published by Korean Society of Applied Pharmacology. It's publishing house is located in South Korea. Coverage history of this journal is as following: 2008-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Biomolecules and Therapeutics is Biomol. Ther.. This abbreviation ('Biomol. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Biomolecules and Therapeutics


If your research field is/are related to Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Biomolecules and Therapeutics?

Biomolecules and Therapeutics latest impact IF is 4.04. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.45 (2020) and 1.93 (2014), respectively, in the last 9 years. Moreover, its average IS is 3.32 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics has an SJR (SCImago Journal Rank) of 0.882, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.993 in 2016 and the lowest being 0.441 in 2014. Furthermore, the average SJR of the Biomolecules and Therapeutics over the previous 9-year period stands at 3.32.


What's the latest h-index of the Biomolecules and Therapeutics?

The latest h-index of the Biomolecules and Therapeutics is 49.


Who's the publisher of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics is published by the Korean Society of Applied Pharmacology, with its country of publication being the South Korea.


What's the current ranking of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics is currently ranked 5127 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 4316 in 2021 and its lowest position of 9906 in 2014.


What's the abbreviation or short name for the Biomolecules and Therapeutics?

The standard ISO4 abbreviation for the Biomolecules and Therapeutics is Biomol. Ther..


Is the "Biomolecules and Therapeutics" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Biomolecules and Therapeutics is classified as a journal that the Korean Society of Applied Pharmacology publishes.


What's the scope or major areas of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics encompasses the following areas:

  • Drug Discovery
  • Biochemistry
  • Molecular Medicine
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 19769148, 20054483.


What's the best quartile of the Biomolecules and Therapeutics?

The best quartile for the Biomolecules and Therapeutics is Q1 (2022).


What's the coverage history of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics coverage history can be summarized as follows: 2008-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
British Journal of Special Education journal 12024 Wiley-Blackwell Publishing Ltd 42 1.24
European Surgery - Acta Chirurgica Austriaca journal 16873 Springer Medizin 23 0.58
Exploration Geophysics journal 16383 Taylor and Francis Ltd. 48 1.17
Journal des Professionnels de l'Enfance journal 27577 TPMA 2 0.00
SPE International Formation Damage Control Symposium Proceedings conference and proceedings 21934 16 0.00
Transboundary and Emerging Diseases journal 4279 Wiley-Blackwell Publishing Ltd 78 4.95
International Journal of Organizational Analysis journal 8713 Emerald Group Publishing Ltd. 36 3.53

Check complete list




Year wise Impact Score (IS) of Biomolecules and Therapeutics

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 4.04
2021 4.35
2020 4.45
2019 3.44
2018 3.14
2017 2.75
2016 2.99
2015 2.76
2014 1.93



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All

Top Journals/Conferences in Biochemistry

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

Annual Review of Biophysics
Annual Reviews Inc. | United States

Chem
Elsevier Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All